Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

LAMEA Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Country and Growth Forecast, 2024 - 2031

Published Date : 08-May-2024

Pages: 140

Formats: PDF

The Latin America, Middle East and Africa Drug Discovery Informatics Market would witness market growth of 12.8% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Drug Discovery Informatics Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $133 million by 2031. The Argentina market is showcasing a CAGR of 13.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 12.4% during (2024 - 2031).

LAMEA Drug Discovery Informatics Market

Drug discovery informatics, also known as cheminformatics or pharmaceutical informatics, uses computational and informational techniques to discover new drugs. It encompasses a range of methods and technologies used by pharmaceutical and biotechnology companies and academic researchers to streamline and enhance the drug discovery process. Drug discovery informatics is revolutionizing the pharmaceutical industry by leveraging computational tools and data-driven approaches to expedite drug discovery.

Additionally, by harnessing the power of big data, advanced algorithms, and predictive modeling, drug discovery informatics enables researchers to identify promising drug targets, design optimized compounds, and predict their potential efficacy and safety profiles. Researchers can efficiently use vast chemical libraries to identify lead compounds with therapeutic potential through virtual screening, molecular modeling, and structure-activity relationship (SAR) analysis.

Rapid changes in lifestyle behaviors, such as unhealthy diet, physical inactivity, tobacco use, and alcohol consumption, contribute to the increasing burden of cardiovascular disease (CVD) in this region. Urban areas often experience higher rates of sedentary lifestyles and consumption of processed foods, leading to obesity, hypertension, and other risk factors for CVD.

As per Scielo Brazil, the Global Burden of Disease (GBD) Study 2019 and the Brazilian Unified Health System (SUS) database reported that CVDs are Brazil's number one cause of death. According to the GBD Study 2019, CVD prevalence was estimated to be 6.1% of the population and has increased since 1990 due to population growth and aging. Of the CVDs, ischemic heart disease (IHD) was the leading cause of death in the country, followed by stroke in 1990 and 2019. In 2019, there were 171,246 deaths due to IHD in Brazil, corresponding to 12% of total deaths in the country and 43% of all CVD deaths. Therefore, with the high prevalence of chronic diseases like cancer and CVD, the drug discovery informatics market is expected to grow continuously.

Free Valuable Insights: The Worldwide Drug Discovery Informatics Market is Projected to reach USD 6.5 Billion by 2031, at a CAGR of 10.3%

Based on Application, the market is segmented into Drug Discovery, and Drug Development. Based on Function, the market is segmented into Sequencing & Target Data Analysis, Molecular Modelling, Library & Database Preparation, Docking, and Others. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Oracle Corporation
  • Accenture PLC
  • Thermo Fisher Scientific, Inc.
  • Boehringer Ingelheim International GmbH
  • Infosys Limited
  • Charles River Laboratories International, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Certara, Inc.
  • Jubilant Pharmova Limited

LAMEA Drug Discovery Informatics Market Report Segmentation

By Application

  • Drug Discovery
  • Drug Development

By Function

  • Sequencing & Target Data Analysis
  • Molecular Modelling
  • Library & Database Preparation
  • Docking
  • Others

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Drug Discovery Informatics Market, by Application
1.4.2 LAMEA Drug Discovery Informatics Market, by Function
1.4.3 LAMEA Drug Discovery Informatics Market, by End User
1.4.4 LAMEA Drug Discovery Informatics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
4.4 Porter’s Five Forces Analysis

Chapter 5. LAMEA Drug Discovery Informatics Market by Application
5.1 LAMEA Drug Discovery Market by Country
5.2 LAMEA Drug Development Market by Country

Chapter 6. LAMEA Drug Discovery Informatics Market by Function
6.1 LAMEA Sequencing & Target Data Analysis Market by Country
6.2 LAMEA Molecular Modelling Market by Country
6.3 LAMEA Library & Database Preparation Market by Country
6.4 LAMEA Docking Market by Country
6.5 LAMEA Others Market by Country

Chapter 7. LAMEA Drug Discovery Informatics Market by End User
7.1 LAMEA Pharmaceutical Companies Market by Country
7.2 LAMEA Biotechnology Companies Market by Country
7.3 LAMEA Contract Research Organizations Market by Country
7.4 LAMEA Others Market by Country

Chapter 8. LAMEA Drug Discovery Informatics Market by Country
8.1 Brazil Drug Discovery Informatics Market
8.1.1 Brazil Drug Discovery Informatics Market by Application
8.1.2 Brazil Drug Discovery Informatics Market by Function
8.1.3 Brazil Drug Discovery Informatics Market by End User
8.2 Argentina Drug Discovery Informatics Market
8.2.1 Argentina Drug Discovery Informatics Market by Application
8.2.2 Argentina Drug Discovery Informatics Market by Function
8.2.3 Argentina Drug Discovery Informatics Market by End User
8.3 UAE Drug Discovery Informatics Market
8.3.1 UAE Drug Discovery Informatics Market by Application
8.3.2 UAE Drug Discovery Informatics Market by Function
8.3.3 UAE Drug Discovery Informatics Market by End User
8.4 Saudi Arabia Drug Discovery Informatics Market
8.4.1 Saudi Arabia Drug Discovery Informatics Market by Application
8.4.2 Saudi Arabia Drug Discovery Informatics Market by Function
8.4.3 Saudi Arabia Drug Discovery Informatics Market by End User
8.5 South Africa Drug Discovery Informatics Market
8.5.1 South Africa Drug Discovery Informatics Market by Application
8.5.2 South Africa Drug Discovery Informatics Market by Function
8.5.3 South Africa Drug Discovery Informatics Market by End User
8.6 Nigeria Drug Discovery Informatics Market
8.6.1 Nigeria Drug Discovery Informatics Market by Application
8.6.2 Nigeria Drug Discovery Informatics Market by Function
8.6.3 Nigeria Drug Discovery Informatics Market by End User
8.7 Rest of LAMEA Drug Discovery Informatics Market
8.7.1 Rest of LAMEA Drug Discovery Informatics Market by Application
8.7.2 Rest of LAMEA Drug Discovery Informatics Market by Function
8.7.3 Rest of LAMEA Drug Discovery Informatics Market by End User

Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Accenture PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Infosys Limited
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Charles River Laboratories International, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.6.5 SWOT Analysis
9.7 Agilent Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Illumina, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segment and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Certara, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.9.6 SWOT Analysis
9.10. Jubilant Pharmova Limited
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 SWOT Analysis
TABLE 1 LAMEA Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Drug Discovery Informatics Market
TABLE 4 Product Launches And Product Expansions– Drug Discovery Informatics Market
TABLE 5 Acquisition and Mergers– Drug Discovery Informatics Market
TABLE 6 LAMEA Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 7 LAMEA Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 8 LAMEA Drug Discovery Market by Country, 2020 - 2023, USD Million
TABLE 9 LAMEA Drug Discovery Market by Country, 2024 - 2031, USD Million
TABLE 10 LAMEA Drug Development Market by Country, 2020 - 2023, USD Million
TABLE 11 LAMEA Drug Development Market by Country, 2024 - 2031, USD Million
TABLE 12 LAMEA Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 13 LAMEA Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 14 LAMEA Sequencing & Target Data Analysis Market by Country, 2020 - 2023, USD Million
TABLE 15 LAMEA Sequencing & Target Data Analysis Market by Country, 2024 - 2031, USD Million
TABLE 16 LAMEA Molecular Modelling Market by Country, 2020 - 2023, USD Million
TABLE 17 LAMEA Molecular Modelling Market by Country, 2024 - 2031, USD Million
TABLE 18 LAMEA Library & Database Preparation Market by Country, 2020 - 2023, USD Million
TABLE 19 LAMEA Library & Database Preparation Market by Country, 2024 - 2031, USD Million
TABLE 20 LAMEA Docking Market by Country, 2020 - 2023, USD Million
TABLE 21 LAMEA Docking Market by Country, 2024 - 2031, USD Million
TABLE 22 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 23 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 24 LAMEA Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 25 LAMEA Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 26 LAMEA Pharmaceutical Companies Market by Country, 2020 - 2023, USD Million
TABLE 27 LAMEA Pharmaceutical Companies Market by Country, 2024 - 2031, USD Million
TABLE 28 LAMEA Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 29 LAMEA Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 30 LAMEA Contract Research Organizations Market by Country, 2020 - 2023, USD Million
TABLE 31 LAMEA Contract Research Organizations Market by Country, 2024 - 2031, USD Million
TABLE 32 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 33 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 34 LAMEA Drug Discovery Informatics Market by Country, 2020 - 2023, USD Million
TABLE 35 LAMEA Drug Discovery Informatics Market by Country, 2024 - 2031, USD Million
TABLE 36 Brazil Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 37 Brazil Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 38 Brazil Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 39 Brazil Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 40 Brazil Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 41 Brazil Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 42 Brazil Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 43 Brazil Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 44 Argentina Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 45 Argentina Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 46 Argentina Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 47 Argentina Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 48 Argentina Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 49 Argentina Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 50 Argentina Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 51 Argentina Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 52 UAE Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 53 UAE Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 54 UAE Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 55 UAE Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 56 UAE Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 57 UAE Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 58 UAE Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 59 UAE Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 60 Saudi Arabia Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 61 Saudi Arabia Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 62 Saudi Arabia Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 63 Saudi Arabia Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 64 Saudi Arabia Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 65 Saudi Arabia Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 66 Saudi Arabia Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 67 Saudi Arabia Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 68 South Africa Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 69 South Africa Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 70 South Africa Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 71 South Africa Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 72 South Africa Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 73 South Africa Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 74 South Africa Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 75 South Africa Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 76 Nigeria Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 77 Nigeria Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 78 Nigeria Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 79 Nigeria Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 80 Nigeria Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 81 Nigeria Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 82 Nigeria Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 83 Nigeria Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 84 Rest of LAMEA Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 85 Rest of LAMEA Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 86 Rest of LAMEA Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 87 Rest of LAMEA Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 88 Rest of LAMEA Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 89 Rest of LAMEA Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 90 Rest of LAMEA Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 91 Rest of LAMEA Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 92 Key Information – Oracle Corporation
TABLE 93 Key Information – Accenture PLC
TABLE 94 Key Information – Thermo Fisher Scientific, Inc.
TABLE 95 Key Information – Boehringer Ingelheim International GmbH
TABLE 96 Key Information – Infosys Limited
TABLE 97 key information – Charles River Laboratories International, Inc.
TABLE 98 key Information – Agilent Technologies, Inc.
TABLE 99 key information – Illumina, Inc.
TABLE 100 Key Information – Certara, Inc.
TABLE 101 Key Information – Jubilant Pharmova Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Drug Discovery Informatics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Drug Discovery Informatics Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
FIG 7 Porter’s Five Forces Analysis - Drug Discovery Informatics Market
FIG 8 LAMEA Drug Discovery Informatics Market share by Application, 2023
FIG 9 LAMEA Drug Discovery Informatics Market share by Application, 2031
FIG 10 LAMEA Drug Discovery Informatics Market by Application, 2020 - 2031, USD Million
FIG 11 LAMEA Drug Discovery Informatics Market share by Function, 2023
FIG 12 LAMEA Drug Discovery Informatics Market share by Function, 2031
FIG 13 LAMEA Drug Discovery Informatics Market by Function, 2020 - 2031, USD Million
FIG 14 LAMEA Drug Discovery Informatics Market share by End User, 2023
FIG 15 LAMEA Drug Discovery Informatics Market share by End User, 2031
FIG 16 LAMEA Drug Discovery Informatics Market by End User, 2020 - 2031, USD Million
FIG 17 LAMEA Drug Discovery Informatics Market share by Country, 2023
FIG 18 LAMEA Drug Discovery Informatics Market share by Country, 2031
FIG 19 LAMEA Drug Discovery Informatics Market by Country, 2020 - 2031, USD Million
FIG 20 SWOT Analysis: Oracle Corporation
FIG 21 SWOT Analysis: Accenture PLC
FIG 22 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 24 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 25 SWOT Analysis: Infosys Limited
FIG 26 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 27 Swot Analysis: Charles River Laboratories International, Inc.
FIG 28 Recent strategies and developments: Agilent Technologies, Inc.
FIG 29 Swot Analysis: Agilent Technologies, Inc.
FIG 30 Recent strategies and developments: Illumina, Inc.
FIG 31 Swot Analysis: Illumina, Inc.
FIG 32 Recent strategies and developments: Certara, Inc.
FIG 33 Swot Analysis: Certara, Inc.
FIG 34 Swot Analysis: Jubilant Pharmova Limited

Purchase Full Report of
LAMEA Drug Discovery Informatics Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL